US EditionFrench-Owned Pharmaceutical Company Egis Plans Huge Investment in Hungary
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
The state also supports the investment.
French-owned pharmaceutical company Egis plans huge investment in Hungary
Hungarian pharmaceutical company Egis will spend HUF 14.5bn on expanding capacity its base in Körmend (Western Hungary). The investment is supported by a HUF 3.5bn government grant, Minister of Foreign Affairs and Trade Péter Szijjártó said on Monday. Egis today employs 3,800 people in Hungary, the minister said. It spent HUF 20bn on research and development last year and makes over 650 pharmaceutical products in the country. Szijjártó noted tha…
Péter Szijjártó, Minister of Foreign Affairs and Trade, spoke about the support for EGIS.
The Hungarian government is providing several billion forints of support for the Egis Pharmaceuticals plant in Körmend. As Minister of Foreign Affairs and Trade Péter Szijjártó indicated at the announcement, the Hungarian pharmaceutical industry is not only a strategic sector of the economy, but also belongs to the forefront of the world.
The pharmaceutical company from Kőbánya is spending more than 14.5 billion forints to expand the capacities of its factory in Vas County. The government will continue to provide all support in the future to ... ...
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
